P-841 A pilot study to assess the incidence of constipation in patientsreceiving vinca-alkaloid chemotherapy for lung cancer and to evaluate their self-care actions

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S341
Author(s):  
K. Priest ◽  
A. Norton ◽  
M. O'Brien
1986 ◽  
Vol 20 (4) ◽  
pp. 287-289 ◽  
Author(s):  
Karen L. Hoelzer ◽  
Bruce R. Harrison ◽  
Susan W. Luedke ◽  
Dan W. Luedke

Two of 33 patients entered in a local pilot study of mitomycin, vinblastine, and cisplatin for non-small cell lung cancer developed vinblastine-associated pulmonary toxicity. As with other reports of vinca alkaloid-related pulmonary toxicity, the regimen included mitomycin. Based on these cases and others previously reported, the incidence of abrupt pulmonary toxicity following vinca alkaloid administration as part of mitomycin/vinca alkaloid combination appears to be three to six percent. Suggestions for management are given.


2017 ◽  
Vol 25 (2) ◽  
pp. 292-303 ◽  
Author(s):  
Tom Lloyd ◽  
Harleah Buck ◽  
Andrew Foy ◽  
Sara Black ◽  
Antony Pinter ◽  
...  

Lung Cancer ◽  
2014 ◽  
Vol 83 ◽  
pp. S50-S51
Author(s):  
S. Morgan ◽  
F. Daniels

Sign in / Sign up

Export Citation Format

Share Document